Skadden advised Vertex Pharmaceuticals Incorporated on the deal while Cooley represented ViaCyte. Vertex Pharmaceuticals Incorporated (“Vertex”) has entered into a definitive agreement under which Vertex will acquire...
Vertex’s $320 Million Acquisition of ViaCyte
COVA Acquisition’s $3.82 Billion De-Spac Merger with ECARX
UBS AG Hong Kong Branch(1) and Morgan Stanley Asia Limited acted as joint financial advisors to ECARX. Skadden, Arps, Slate, Meagher & Flom, together with Maples...
Grupo Werthein’s Acquisition of AT&T’s Vrio Corp. Business Unit
Grupo Werthein is represented in the U.S. by Skadden, Arps, Slate, Meagher & Flom, LLP, Demarest, Bruchou, Fernandez Madero & Lombardi, Carey, Posse Herrera Ruiz, Bustamante...